Total Payments
$355.09
2023 Payments
$19.46
Companies
8
Transactions
16
Medicare Patients
2,821
Medicare Billing
$366,490
Payment Breakdown by Category
Food & Beverage$355.09 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $355.09 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $75.21 | 5 | $0 (2019) |
| Melinta Therapeutics, Inc. | $74.51 | 1 | $0 (2019) |
| PFIZER INC. | $56.60 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $52.58 | 4 | $0 (2021) |
| Derma Sciences, Inc. | $34.36 | 1 | $0 (2017) |
| ABBVIE INC. | $26.84 | 1 | $0 (2022) |
| UCB, Inc. | $19.46 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $15.53 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.46 | 1 | UCB, Inc. ($19.46) |
| 2022 | $26.84 | 1 | ABBVIE INC. ($26.84) |
| 2021 | $42.23 | 3 | AstraZeneca Pharmaceuticals LP ($26.70) |
| 2020 | $25.88 | 2 | AstraZeneca Pharmaceuticals LP ($25.88) |
| 2019 | $125.75 | 3 | Melinta Therapeutics, Inc. ($74.51) |
| 2018 | $68.43 | 4 | Allergan Inc. ($45.27) |
| 2017 | $46.50 | 2 | Derma Sciences, Inc. ($34.36) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Neurology | ||||||
| 10/11/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/17/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: COVID-19 | ||||||
| 07/12/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/13/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/12/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $74.51 | General |
| Category: ANTIBIOTICS | ||||||
| 05/03/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/13/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/27/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/05/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/13/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/15/2017 | Derma Sciences, Inc. | MEDIHONEY (Device), AMNIOEXCEL, TCC-EZ | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: Recon-Skin and Wound | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 650 | 687 | $1.2M | $85,532 |
| 2022 | 5 | 626 | 658 | $1.3M | $87,144 |
| 2021 | 5 | 598 | 617 | $1.2M | $86,431 |
| 2020 | 6 | 947 | 985 | $1.5M | $107,384 |
Total Patients
2,821
Total Services
2,947
Medicare Billing
$366,490
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 379 | 405 | $714,429 | $52,793 | 7.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 122 | 127 | $265,183 | $20,316 | 7.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 132 | 138 | $173,129 | $11,619 | 6.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 17 | 17 | $13,064 | $804.01 | 6.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 385 | 412 | $850,343 | $57,469 | 6.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 103 | 104 | $264,142 | $18,293 | 6.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 86 | 88 | $126,060 | $7,933 | 6.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 20 | 21 | $26,586 | $1,752 | 6.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 32 | 33 | $27,806 | $1,697 | 6.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 310 | 324 | $671,646 | $49,044 | 7.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 127 | 130 | $330,664 | $24,917 | 7.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 96 | 97 | $139,908 | $8,563 | 6.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 51 | 52 | $44,671 | $2,715 | 6.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 14 | 14 | $17,724 | $1,191 | 6.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 419 | 444 | $845,124 | $59,958 | 7.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 166 | 174 | $427,140 | $29,911 | 7.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 130 | 131 | $169,283 | $11,763 | 6.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 52 | 52 | $37,182 | $2,493 | 6.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 25 | 25 | $15,475 | $2,196 | 14.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 155 | 159 | $15,900 | $1,061 | 6.7% |
About Dr. William Bickell, MD
Dr. William Bickell, MD is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861459570.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Bickell, MD has received a total of $355.09 in payments from pharmaceutical and medical device companies, with $19.46 received in 2023. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($355.09).
As a Medicare-enrolled provider, Bickell has provided services to 2,821 Medicare beneficiaries, totaling 2,947 services with total Medicare billing of $366,490. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Tulsa, OK
- Active Since 04/27/2006
- Last Updated 05/23/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1861459570
Products in Payments
- Orbactiv (Drug) $74.51
- ELIQUIS (Drug) $56.60
- LOKELMA (Drug) $52.58
- TEFLARO (Drug) $50.80
- DALVANCE (Drug) $38.98
- MEDIHONEY (Device) $34.36
- Briviact (Drug) $19.46
- Veklury (Drug) $15.53
- AVYCAZ (Drug) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Emergency Medicine $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Emergency Medicine $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
Emergency Medicine $5,156
Trung Pham, D.o, D.O
Emergency Medicine — Payments: $3,718
Emergency Medicine $3,718
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Emergency Medicine $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507
Emergency Medicine $1,507